Kang Ho Suk, Kim Joo-Hee, Bang Woo Jin, Yoo Dae Myoung, Han Kyeong Min, Kim Nan Young, Choi Hyo Geun, Park Ha Young, Kwon Mi Jung
Division of Gastroenterology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of Korea.
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of Korea.
Biomedicines. 2025 Aug 11;13(8):1956. doi: 10.3390/biomedicines13081956.
: Chronic kidney disease (CKD) and osteoporosis are critical public health concerns, particularly among older adults, due to their prevalence and associated complications. While CKD-related disruptions in bone mineral metabolism are believed to increase osteoporosis risk, this relationship remains unclear in diverse populations such as Korea. : This longitudinal cohort study utilized data from the Korean National Health Insurance Service Health Screening Cohort (2002-2019), including 13,622 patients with newly diagnosed CKD and 54,488 matched controls. CKD was defined as having at least two outpatient or inpatient records with ICD-10 codes N18 or N19 and/or evidence of dialysis treatment claims, following a 1-year washout period to exclude prevalent cases. Individuals with a prior history of osteoporosis or incomplete baseline data were excluded. Propensity score overlap weighting was applied, and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using Cox proportional hazards models, with subgroup analyses based on demographic and clinical factors. : CKD was not associated with an increased risk of osteoporosis. On the contrary, CKD patients exhibited an 18% lower risk of developing osteoporosis compared to controls (HR = 0.82, 95% CI: 0.77-0.87, < 0.001). This inverse association was more pronounced among women, non-smokers, individuals with low alcohol consumption, and those with a higher comorbidity burden. : These findings suggest that certain subgroups of CKD patients may have a reduced risk of osteoporosis, highlighting the importance of individualized risk assessment and tailored preventive strategies.
慢性肾脏病(CKD)和骨质疏松症是重大的公共卫生问题,尤其是在老年人中,这是由于它们的患病率和相关并发症所致。虽然人们认为CKD相关的骨矿物质代谢紊乱会增加骨质疏松症的风险,但在韩国等不同人群中,这种关系仍不明确。
这项纵向队列研究利用了韩国国民健康保险服务健康筛查队列(2002 - 2019年)的数据,其中包括13622例新诊断的CKD患者和54488例匹配的对照。CKD的定义为至少有两份门诊或住院记录,其ICD - 10编码为N18或N19,和/或有透析治疗索赔的证据,经过1年的洗脱期以排除现患病例。有骨质疏松症既往史或基线数据不完整的个体被排除。应用倾向得分重叠加权法,并使用Cox比例风险模型计算调整后的风险比(HR)及95%置信区间(CI),并根据人口统计学和临床因素进行亚组分析。
CKD与骨质疏松症风险增加无关。相反,与对照组相比,CKD患者发生骨质疏松症的风险低18%(HR = 0.82,95% CI:0.77 - 0.87,P < 0.001)。这种负相关在女性、非吸烟者、低酒精摄入量者以及合并症负担较高者中更为明显。
这些发现表明,某些CKD患者亚组可能患骨质疏松症的风险较低,凸显了个体化风险评估和量身定制预防策略的重要性。